Ligand Pharmaceuticals Incorporated (LGND) Dropped -12.54% or -15.12 To Price $105.49 On Wednesday


Ligand Pharmaceuticals Incorporated (LGND) dropped -12.54% or -15.12 to $105.49. It is about 2.90 million shares traded, which is 598.31% compare to the average total volume 483963. The market cap of LGND is $2.16 billion. The year to date change is -24.5%. The 52 week price range is from $98.56 to $278.62. Price of LGND have changed -4.84% during last week. It have changed 3.15% over last month, -21.47% over last 3 months, -52.59% over last 6 months and -25.76% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for LGND is 124.33. It is 17.86% above current price. The 200-day Moving Averages for LGND is 186.78. It is 77.06% above current price. The 52-week High is 278.62. It is 164.12% from the current price. The 52-week Low is 98.56. It is -6.57% from current price.

There are some statistics of LGND. It is has market cap $2.16 billion. The share outstanding is 20.45 million. The average volume is 483963. The percent of top 15 Institution holding is 182.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of LGND is 29.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of LGND is 14.84%.


Tags:

Share this post